-
Gaps in End-of-Life Care
Racial and ethnic backgrounds can be factors in whether cancer patients take advantage of hospice care. Researchers and clinicians are trying to understand the gaps and design strategies to bridge them.
by Charlotte Huff
-
A Call to Care
Caregivers for cancer patients find themselves playing a complex and vital role as care shifts from the hospital to the home.
by Kate Yandell
-
Targeting Brain Cancer
Researchers are trying to understand brain cancer at the molecular level. Their goal is to find new, more effective therapies for this hard-to-treat disease.
by Stephen Ornes
-
The Cost of Treatment
As efforts to change or repeal the Affordable Care Act continue, health care bills keep piling up for many cancer patients and caregivers.
by Sue Rochman
-
In the Moment- Winter 2017/2018
Lauren Chiarello Mika, Sandy Russell, Christopher Rios.
-
Vaccines: Looking Within for Cancer Treatment
Researchers are testing treatment vaccines that spur the immune system to attack cancer.
by Stephen Ornes
-
Cancer Control in the Community
Successful public health initiatives to prevent, detect and treat cancer require widespread community participation.
by Marci A. Landsmann
-
Advocacy in Action
Fearless FriendsLori Marx-Rubiner and AnneMarie Ciccarella met on social media and grew close through their cancer research advocacy.
by Sue Rochman
-
Challenges Remain for Kids With Cancer
More children are being treated successfully for cancer. Yet researchers continue searching for new therapies that will help kids who don't respond to standard treatments.
by Cameron Walker
-
In the Moment- Fall 2017
Wanda Huskins, Renee Soriano, Holly Hamer.
Cancer Talk
Immunotherapy Improves Survival in Bladder Cancer
New research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
2024: The Year in Cancer NewsThe Cancer Today editors share the most impactful reporting on cancer research from 2024.
by Cancer Today staff